Common herpes virus causes signs of Alzheimer’s disease in brain cells
and leprechauns!
Scientists discover protective Alzheimer’s gene and develop rapid drug-testing platform
Sounds like these guys are serious:
Roche gains rights to Alzheimer’s drug in $120M deal
Roche announced a licensing deal with Belgian pharma company UCB for global rights to UCB0107, which targets the tau protein associated with Alzheimer’s disease. UCB will continue to be responsible for the funding and conduct of a proof-of-concept study, after which, upon the study’s completion, Genentech, a Roche subsidiary, may opt to continue development of UCB0107 or return its rights. [Note, if they opt to continue, total payments could amount to 2 Billion $. Mike]
Full Story: Xconomy (7/29)
Protein involved in removing Alzheimer’s buildup linked to circadian rhythm
In surprising twist, some Alzheimer’s plaques may be protective, not destructive
https://www.salk.edu/news-release/in-surprising-twist-some-alzheimers-plaques-may-be-protective-not-destructive/
ABOARD - A Personalized Medicine Approach for Alzheimer’s Disease.
A project in the Netherlands, which has started on the 1st of April 2021 and will last for five years,
which focusses on a future with personalised diagnosis, prediction and prevention of Alzheimer’s Disease.
It contains opportunities to contribute with voluntary work e.g. as a participant for research, training on how to deal with Alzheimer’s Disease, factsheets, testresults, and much more.
Website with a short summary in English:
As reported by “The Economist” Magazine:
America’s wary approval of an Alzheimer’s drug offers hope to millions | The Economist
I should add this later caveat, also from The Economist: " The approval granted by America’s Food and Drug Administration to a new drug to combat Alzheimer’s disease was hailed as a breakthrough, even though the FDA conceded that the drug, aducanumab (to be marketed as Aduhelm), is not proven to work. It has shown success in reducing the build-up in the brain of a protein known as beta-amyloid, one of the possible causes of Alzheimer’s. Biogen must now conduct a large-scale clinical trial to determine whether it does also slow memory loss and cognitive decline."
I would like to share an article I wrote about Stallcatchers. Hope you like it! 
’
Great job! Thank you, orbithunter!